Browsing by Contributors Wolchok, Jedd D

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 15 of 15
PreviewIssue DateTitleContributor(s)
2017 Nature Volume 545 Issue 7655 May (49).pdf.jpg2017Chromatin states define tumour-specific T cell dysfunction and reprogrammingPhilip, Mary; Fairchild, Lauren; Sun, Liping; Horste, Ellen L; Camara, Steven; Shakiba, Mojdeh; Scott, Andrew C; Viale, Agnes; Lauer, Peter; Merghoub, Taha; Hellmann, Matthew D; Wolchok, Jedd D; Leslie, Christina S
1270.pdf.jpg24-Sep-2015Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaLarkin, James; Hodi, F Stephen; Wolchok, Jedd D
23.pdf.jpg2-Jul-2015Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaLarkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean Jacques; Cowey, C Lance; Lao, Christopher D; Schadendorf, Dirk; Dummer, Reinhard; Smylie, Michael; Rutkowski, Piotr; Ferrucci, Pier F; Hill, Andrew; Wagstaff, John; Carlino, Matteo S; Haanen, John B; Maio, Michele; Marquez-Rodas, Ivan; McArthur, Grant A; Ascierto, Paolo A; Long, Georgina V; Callahan, Margaret K; Postow, Michael A; Grossmann, Kenneth; Sznol, Mario; Dreno, Brigitte; Bastholt, Lars; Yang, Arvin; Rollin, Linda M; Horak, Christine; Hodi, F Stephen; Wolchok, Jedd D
2011Defining the Critical Hurdles in Cancer ImmunotherapyFox, Bernard A; Schendel, Dolores J; Butterfield, Lisa H; Aamdal, Steinar; Allison, James P; Ascierto, Paolo Antonio; Atkins, Michael B; Bartunkova, Jirina; Bergmann, Lothar; Berinstein, Neil; Bonorino, Cristina C; Borden, Ernest; Bramson, Jonathan L; Britten, Cedrik M; Cao, Xuetao; Carson, William E; Chang, Alfred E; Characiejus, Dainius; Coukos, George; de Gruijl, Tanja; Dillman, Robert O; Dolstra, Harry; Durrant, Lindy G; Finke, James H; Galon, Jerome; Gollob, Jared A; Gouttefangeas, Cécile; Grizzi, Fabio; Guida, Michele; Håkansson, Leif; Hege, Kristen; Herberman, Ronald B; Hoos, Axel; Huber, Christoph; Hwu, Patrick; Imai, Kohzoh; Jaffee, Elizabeth M; Janetzki, Sylvia; June, Carl H; Kalinski, Pawel; Kaufman, Howard L; Kawakami, Koji; Kawakami, Yutaka; Keilholtz, Ulrich; Khleif, Samir N; Kiessling, Rolf; Kotlan, Beatrix; Kroemer, Guido; Lapointe, Rejean; Levitsky, Hyam I; Lotze, Michael T; Maccalli, Cristina; Maio, Michele; Marschner, Jens-Peter; Mastrangelo, Michael J; Masucci, Giuseppe; Melero, Ignacio; Melief, Cornelius; Nelson, Brad; Nicolini, Andrea; Nishimura, Michael I; Odunsi, Kunle; Ohashi, Pamela S; O'Donnell-Tormey, Jill; Old, Lloyd J; Ottensmeier, Christian; Papamichail, Michael; Parmiani, Giorgio; Pawelec, Graham; Proietti, Enrico; Qin, Shukui; Rees, Robert; Ribas, Antoni; Ridolfi, Ruggero; Ritter, Gerd; Rivoltini, Licia; Romero, Pedro J; Salem, Mohamed L; Scheper, Rik J; Seliger, Barbara; Sharma, Padmanee; Shiku, Hiroshi; Singh-Jasuja, Harpreet; Song, Wenru; Straten, Per Thor; Tahara, Hideaki; Tian, Zhigang; van Der Burg, Sjoerd H; von Hoegen, Paul; Wang, Ena; Welters, Marij JP; Winter, Hauke; Withington, Tara; Wolchok, Jedd D; Xiao, Weihua; Zitvogel, Laurence; Zwierzina, Heinz; Marincola, Francesco M; Gajewski, Thomas F; Wigginton, Jon M; Disis, Mary L; Choudhury, A. Raja; Dranoff, Glenn; Hodi, Frank Stephen; Murphy, William J.
JoCO 2018 Volume 36 Issue 17 June (3).pdf.jpg2018Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic MelanomaRobert, Caroline; Ribas, Antoni; Hamid, Omid; Daud, Adil; Wolchok, Jedd D; Joshua, Anthony M; Hwu, Wen-jen; Weber, Jeffrey S; Gangadhar, Tara C; Joseph, Richard W; Dronca, Roxana; Patnaik, Amita; Zarour, Hassane; Hersey, Peter; Zhang, Jin; Anderson, James; Diede, Scott J
783.pdf.jpg19-Feb-2015Genetic basis for clinical response to CTLA-4 blockadeSnyder, Alexandra; Wolchok, Jedd D; Chan, Timothy A
2018 JoCO Volume 36 Issue 9 March (4).pdf.jpg2018Immune-Modi fi ed Response Evaluation Criteria In Solid Tumors ( imRECIST ): Re fi ning Guidelines to Assess the Clinical Bene fi t of Cancer ImmunotherapyHodi, F Stephen; Ballinger, Marcus; Lyons, Benjamin; Soria, Jean-charles; Nishino, Mizuki; Tabernero, Josep; Powles, Thomas; Smith, David; Hoos, Axel; Mckenna, Chris; Beyer, Ulrich; Rhee, Ina; Fine, Gregg; Winslow, Nathan; Chen, Daniel S; Wolchok, Jedd D
2006.pdf.jpg21-May-2015Nivolumab and ipilimumab versus ipilimumab in untreated melanomaPostow, Michael A; Chesney, Jason; Pavlick, Anna C; Robert, Caroline; Grossmann, Kenneth; McDermott, David; Linette, Gerald P; Meyer, Nicolas; Giguere, Jeffrey K; Agarwala, Sanjiv S; Shaheen, Montaser; Ernstoff, Marc S; Minor, David; Salama, April K; Taylor, Matthew; Ott, Patrick A; Rollin, Linda M; Horak, Christine; Gagnier, Paul; Wolchok, Jedd D; Hodi, F Stephen
2018 JoCO Volume 36 Issue 4 February (13).pdf.jpg2018Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma : Updated Survival , Response , and Safety Data in a Phase I Dose-Escalation StudyCallahan, Margaret K; Kluger, Harriet; Postow, Michael A; Segal, Neil H; Lesokhin, Alexander; Atkins, Michael B; Kirkwood, John M; Krishnan, Suba; Horak, Christine; Wolchok, Jedd D; Sznol, Mario
2013Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumabYuan, Jianda; Zhou, Jun; Dong, Zhiwan; Tandon, Sapna; Kuk, Deborah; Panageas, Katherine S; Wong, Philip; Wolchok, Jedd D; Hodi, F Stephen
2016 JCO Volume 34 Issue 34 December (24).pdf.jpg2016Programmed Death-Ligand 1 Expression and Response to the Anti – Programmed Death 1 Antibody Pembrolizumab in MelanomaDaud, Adil I; Wolchok, Jedd D; Robert, Caroline; Hwu, Wen-jen; Weber, Jeffrey S; Ribas, Antoni; Hodi, F Stephen; Joshua, Anthony M; Kefford, Richard; Hersey, Peter; Joseph, Richard; Gangadhar, Tara C; Dronca, Roxana; Patnaik, Amita; Zarour, Hassane; Roach, Charlotte; Tol
2073.pdf.jpg21-May-2015Rapid eradication of a bulky melanoma mass with one dose of immunotherapyChapman, Paul B; D'Angelo, Sandra P; Wolchok, Jedd D
2074.pdf.jpg21-May-2015Rapid eradication of a bulky melanoma mass with one dose of immunotherapyChapman, Paul B; D'Angelo, Sandra P; Wolchok, Jedd D
JCO 2017 Volume 35 Issue 7 March (13).pdf.jpg2017Safety Pro fi le of Nivolumab Monotherapy : A Pooled Analysis of Patients With Advanced MelanomaWeber, Jeffrey S; Hodi, F Stephen; Wolchok, Jedd D; Topalian, Suzanne L; Schadendorf, Dirk; Larkin, James; Sznol, Mario; Long, Georgina V; Li, Hewei; Waxman, Ian M; Jiang, Joel; Robert, Caroline
2016 JCO Volume 34 Issue 31 November (2).pdf.jpg2016T-Cell Therapy Using Interleukin-21 – Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor RegressionChapuis, Aude G; Roberts, Ilana M; Thompson, John A; Margolin, Kim A; Bhatia, Shailender; Lee, Sylvia M; Sloan, Heather L; Lai, Ivy P; Farrar, Erik A; Wagener, Felecia; Shibuya, Kendall C; Cao, Jianhong; Wolchok, Jedd D; Greenberg, Philip D; Yee, Cassian; Farrar, Erik A